Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene

M D Pinho1, J Melo-Cristino, M Ramirez

  • 1Instituto de Microbiologia, Faculdade de Medicina Lisboa, Universidade de Lisboa, Lisbon, Portugal.

Insights

Quinolone resistance in Streptococcus dysgalactiae is linked to genetic mutations. Recombination between Streptococcus dysgalactiae and Streptococcus pyogenes may share resistance genes, impacting human infections.

Area of Science:

  • Microbiology
  • Genetics
  • Antimicrobial Resistance

Background:

  • Quinolone resistance is a growing concern in Streptococcus pyogenes infections.
  • Genetic recombination between Streptococcus dysgalactiae and Streptococcus pyogenes is suspected as a key mechanism for resistance.
  • Streptococcus dysgalactiae subspecies equisimilis causes human infections.

Purpose of the Study:

  • To investigate levofloxacin resistance in Streptococcus dysgalactiae subsp. equisimilis.
  • To identify genetic mechanisms underlying quinolone resistance in this species.
  • To explore potential gene sharing between S. dysgalactiae and S. pyogenes.

Main Methods:

  • Characterization of 314 S. dysgalactiae subsp. equisimilis isolates.
  • Pulsed-field gel electrophoresis for genetic profiling.
  • Sequencing of gyrA and parC genes to identify mutations.

Main Results:

  • 12% of isolates exhibited levofloxacin resistance, linked to diverse emm types and lineages.
  • No evidence for efflux pump involvement in resistance.
  • High diversity in parC alleles (19) compared to gyrA alleles (5).
  • Single gyrA or parC mutations conferred intermediate resistance; dual mutations led to higher resistance.
  • Recombination with S. pyogenes DNA observed in some parC alleles, but not solely linked to resistance.

Conclusions:

  • A shared reservoir of quinolone resistance genes likely exists between S. dysgalactiae subsp. equisimilis and S. pyogenes.
  • No evidence of recombination with S. dysgalactiae subsp. dysgalactiae was found.
  • Genetic mutations in gyrA and parC are critical for quinolone resistance development.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...